Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs
- PMID: 837500
- DOI: 10.1161/01.cir.55.4.581
Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs
Abstract
Calcium metabolism may play an important role in the pathogenesis of myocardial ischemic injury. The effect of the sarcolemmal calcium flux inhibitor, verapamil, on myocardial necrosis was studied in dogs subjected to temporary coronary artery occlusion. One group of dogs was untreated. A second group was given 0.8 mg/kg verapamil intravenously over a 30 min period beginning 10 min prior to coronary occlusion. In a third group, the dose of verapamil was increased until complicated by hypotension or conduction abnormalities. Cardiac necrosis was produced in all dogs by 40 min of left circumflex coronary artery occlusion followed by 2--4 days of reperfusion. At the end of the experiment, animals were sacrificed and necrosis was quantitated histologically in transmural slices through the posterior papillary muscle. Pre-treatment with the lower dose of verapamil resulted in significantly less necrosis (14% treated vs 35% untreated) with minimal hemodynamic consequences. Higher does of verapamil were even more effective in limiting cardiac necrosis despite the development of hypotension and varying degrees of heart block.
Similar articles
-
Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.Lab Invest. 1984 Dec;51(6):655-66. Lab Invest. 1984. PMID: 6503220
-
Reduction in infarct size following experimental coronary occlusion by administration of verapamil.Recent Adv Stud Cardiac Struct Metab. 1975;10:435-52. Recent Adv Stud Cardiac Struct Metab. 1975. PMID: 813284
-
Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.Proc Natl Acad Sci U S A. 1980 Oct;77(10):6119-23. doi: 10.1073/pnas.77.10.6119. Proc Natl Acad Sci U S A. 1980. PMID: 6934538 Free PMC article.
-
Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.Am J Cardiol. 1985 Jan 25;55(3):107B-115B. doi: 10.1016/0002-9149(85)90619-8. Am J Cardiol. 1985. PMID: 3881903 Review.
-
Myocardial protection in the occlusion/reperfusion dog model: the role of ischemic necrosis vs reperfusion injury.Braz J Med Biol Res. 1995 Sep;28(9):951-9. Braz J Med Biol Res. 1995. PMID: 8580882 Review.
Cited by
-
Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.Cardiovasc Drugs Ther. 1988 Sep;2(3):313-23. doi: 10.1007/BF00054638. Cardiovasc Drugs Ther. 1988. PMID: 3154915
-
Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.Basic Res Cardiol. 1985 Jan-Feb;80(1):76-87. doi: 10.1007/BF01906746. Basic Res Cardiol. 1985. PMID: 3985927
-
Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.Basic Res Cardiol. 1979 Sep-Oct;74(5):555-67. doi: 10.1007/BF01907648. Basic Res Cardiol. 1979. PMID: 526260
-
Ultrastructural influence of reperfusing dog myocardium with calcium-free blood after coronary artery occlusion.Am J Pathol. 1978 Feb;90(2):423-34. Am J Pathol. 1978. PMID: 414625 Free PMC article.
-
Calcium antagonists. Pharmacodynamic effects and mechanism of action.Drugs. 1983 Feb;25(2):93-112. doi: 10.2165/00003495-198325020-00001. Drugs. 1983. PMID: 6131809 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources